SLXP Volume Alert - SLXP 93.27 Salix Pharmaceuticals $SLXP

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
SLXP Volume Alert - SLXP 93.27 Salix Pharmaceuticals $SLXP Hit a high of 95.46 Currently 11:15 Last price 93.27 +1.80 +1.97% With a day low of 90.00 and a current volume of 1,957,531.

SLXP Salix Pharmaceuticals Recent Headline News

Wolf Popper LLP Announces Investigation on Behalf of Investors in Salix Pharmaceuticals Ltd.
PR Newswire - 2 hrs 18 mins ago
Wolf Popper LLP is investigating potential claims on behalf of investors in Salix Pharmaceuticals Ltd. ("Salix" common stock (NASDAQ: SLXP) during the period May 10, 2013 through November 6, 2014, concerning possible violations of federal securities laws. Such investors are advised to contact Fei-Lu Qian at 877.370.7703 or fqian@wolfpopper.com.
SLXP: 92.81 (+1.34)

Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals Ltd. -- SLXP
GlobeNewswire - 2 hrs 47 mins ago
Morgan & Morgan announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (Nasdaq:SLXP) securities between November 8, 2013 and November 6, 2014, inclusive (the "Class Period".
SLXP: 92.81 (+1.34)

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST

XBI: 170.53 (+2.81), SLXP: 92.81 (+1.34), ICPT: 177.14 (+4.55), IBB: 293.50 (+3.36), AGIO: 79.91 (+7.85)

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Nov 10, 8:51AM CST
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "dead cat bounce" (down big yesterday but up big today) candidate
SLXP: 92.81 (+1.34)

Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:35AM CST
Salix Pharmaceuticals SLXP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
SLXP: 92.81 (+1.34)

Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation
GlobeNewswire - Mon Nov 10, 8:30AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Salix Pharmaceuticals, Ltd. (SLXP) over alleged Federal Securities Laws Violations by Salix Pharmaceuticals, Ltd.
SLXP: 92.81 (+1.34)

Downgrade Alert for Salix Pharmaceuticals (SLXP)
Comtex SmarTrend(R) - Mon Nov 10, 8:04AM CST
Salix Pharmaceuticals (NASDAQ:SLXP) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $91.47 on volume of 25.8 million shares, above average daily volume of 2.0 million. In the past 52 weeks, shares of Salix Pharmaceuticals have traded between a low of $82.52 and a high of $172.98 and closed yesterday at $91.47, which is 11% above that low price. The 200-day and 50-day moving averages have moved 0.63% higher and 1.83% lower over the past week, respectively.
SLXP: 92.81 (+1.34)

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.34 (+0.02), YHOO: 49.24 (+0.69), MNST: 107.18 (-1.21), ANF: 28.63 (-0.87), SLXP: 92.81 (+1.34), FFIV: 126.55 (-0.11), AKS: 6.62 (unch), TWTR: 39.88 (-0.43), GDX: 17.52 (-1.12), FXF: 100.89 (-0.21)

Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP)
GlobeNewswire - Fri Nov 07, 10:12PM CST
Labaton Sucharow LLP ("Labaton Sucharow" filed a securities class action lawsuit on behalf of Woburn Retirement System in the U.S. District Court for the Southern District of New York. The lawsuit was filed on behalf of all persons or entities who, between November 8, 2013 and November 6, 2014, inclusive (the "Class Period", purchased or otherwise acquired the securities of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (Nasdaq:SLXP).
SLXP: 92.81 (+1.34)

SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - Fri Nov 07, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF", announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP).
SLXP: 92.81 (+1.34)

Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 7:10PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders.
SLXP: 92.81 (+1.34)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.43 (-1.00), LCI: 51.41 (+1.24), AKRX: 35.55 (-1.04), AFSI: 50.40 (+0.51), EXPE: 85.97 (+0.86), FFIV: 126.55 (-0.11), SLXP: 92.81 (+1.34), MPWR: 44.74 (+0.05), TMH: 53.83 (-0.31), ATHM: 44.60 (+0.97)

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.33 (+0.09), PRSC: 37.43 (-1.05), FNGN: 30.80 (-0.59), LACO: 6.92 (+0.01), MSON: 11.30 (-0.50), SLXP: 92.81 (+1.34), FNHC: 26.58 (+0.44), MDRX: 11.31 (-0.23), PCMI: 8.36 (+0.91), UBNT: 29.39 (+0.61), PFMT: 6.66 (-0.38), ICPT: 177.14 (+4.55), ANDE: 53.99 (-0.80), ACTA: 16.61 (+0.09)

Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
Business Wire - Fri Nov 07, 4:23PM CST
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" for possible violations of federal securities laws.
SLXP: 92.81 (+1.34)

Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 92.81 (+1.34), DIS: 89.73 (-0.27), SHLD: 40.15 (-2.66)

Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 195.11 (-0.89), VRX: 127.69 (+1.58), DVA: 74.76 (+0.27), GILD: 107.28 (+0.83), SLXP: 92.81 (+1.34), ICPT: 177.14 (+4.55), HUM: 131.98 (+1.40)

Look for Shares of Salix Pharmaceuticals to Potentially Rebound after Yesterday's 33.98% Sell Off
Comtex SmarTrend(R) - Fri Nov 07, 3:35PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $86.00 to a high of $96.00. Yesterday, the shares fell 34.0%, which took the trading range below the 3-day low of $134.40 on volume of 25.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 92.81 (+1.34)

Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 47.83 (+1.02), TSLA: 241.35 (+1.15), FSLR: 51.76 (+1.47), RIG: 29.34 (-0.37), WWWW: 15.62 (+0.22), GNRC: 40.70 (-0.16), SLXP: 92.81 (+1.34), BRKR: 17.90 (-0.01), KATE: 29.78 (-0.59), GNW: 8.28 (-0.13), SHLD: 40.15 (-2.66), ANR: 2.66 (-0.25), MCO: 99.06 (+0.11), HUM: 131.98 (+1.40)

Dow, S&P 500 Flirt With Record, But Finish Just Off
at Investor's Business Daily - Fri Nov 07, 3:28PM CST
Stocks finished narrowly mixed Friday after the Dow Jones industrial average and the S&P 500 hit record intraday highs, then drifted off in the final hours of trading. The Nasdaq finished down 0.2%, the Dow climbed 0.1% and the S&P 500 was...
MNST: 107.18 (-1.21), SLXP: 92.81 (+1.34), DIS: 89.73 (-0.27)

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 107.18 (-1.21), FSLR: 51.76 (+1.47), SLXP: 92.81 (+1.34), AKS: 6.62 (unch), SHLD: 40.15 (-2.66), VSAT: 62.99 (-2.40)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TilePix Expands into Walmart with Nail-Free Decor Launch

Updated Category News Views 2

TilePix Makes Big Moves with Walmart TilePix is launching their new line of nail-free wall décor at Walmart—this ain’t your grandma’s wall art. This company's bringing their magnetic, nail-free wizardry to retail stores nationwide for the first time, and they’ve chosen a real heavyweight partner—Walmart. What comes in the package? Well, they’re dealing in...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 2

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Costa Rican Firms Chase Growth at SIAL Paris 2026

Updated Category News Views 2

Chasing Growth in Paris: Costa Rica's Bold Move When it comes to playing the global field, Costa Rica isn't just sitting back; they're on the move. Picture this: PROCOMER, along with 18 standout companies, landed smack dab in the grand hustle and bustle of SIAL Paris 2026. This isn't some leisurely stroll—it's a calculated sprint toward expanding their reach across...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 2

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 3

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 50

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Chicago Scenic Studios’ Equipment Up for Grabs in Auction

Updated Category News Views 10

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 35

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 7

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Solvang Teamsters Triumph in Labor Standoff

Updated Category News Views 0

Solvang Strikers Prevail with New Deal Staring down the barrel of a five-week standoff, the hard-nosed workers of Solvang just proved exactly what grit can get you. The City of Solvang and the steadfast members of Teamsters Local 986 wrapped up their punchy back-and-forth by clinching a contract that ups the ante on wages and job respect. For a bunch who stuck it out on...

Continue Reading

Top 5 Most Recently Viewed Articles

Insight into Micron Technology's Options Activity Trends

Updated Category News Views 148

Understanding Micron Technology's Options Activity Investors are making notable bets on Micron Technology (NASDAQ: MU), indicating a bullish perspective among those with significant capital. It is essential for retail traders to pay attention to these developments, as they could signal potential market shifts. Uncommon Options Trades Gather Attention Today, we observed a...

Continue Reading
Understanding the Dynamics of ASML and TSMC in Semiconductors

Updated Category News Views 2074

ASML got slapped with slower recovery forecasts back in 2024, while TSMC kept chugging along—let’s break it down. ASML: Stumbling Giant or Just a Blip? So, ASML was strutting its stuff after showing off revenue growth of around 14% in 2022 and a whopping 30% the following year. Traders were riding high on AI hype, thinking this would just keep rolling into future...

Continue Reading
Indivior's SUBLOCADE Achieves Promising Outcomes in OUD Treatment

Updated Category News Views 96

Indivior's Commitment to Opioid Use Disorder Recovery Indivior PLC, focusing on substance use disorders, is advocating for better access to medications for opioid use disorder (OUD) during Substance Abuse Prevention Month. Their recent studies provide strong evidence supporting the efficacy and safety of SUBLOCADE, a once-monthly extended-release injection of...

Continue Reading
Innovations Shaping the Future of Catering Equipment Market

Updated Category News Views 155

Transformative Trends in Catering Equipment Ahead of HOTELEX 2026 As we look ahead to HOTELEX Shanghai 2026, a premier hospitality and catering trade exhibition, the catering equipment industry is experiencing significant transformation. Set from March 30 to April 2, 2026, this pivotal event will showcase the cutting-edge innovations in the hospitality sector. Driving...

Continue Reading
ERES REIT Announces October Cash Distribution for Investors

Updated Category News Views 117

Monthly Distribution Announced by ERES REIT ERES REIT, known formally as European Residential Real Estate Investment Trust (TSX: ERE.UN), has announced its monthly cash distribution for October. The trustees have declared a distribution of €0.01 per Unit and Class B LP Unit, amounting to an annualized rate of €0.12 per Unit. This October distribution is a testament to...

Continue Reading